This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 5 from Patent US 20070293424
General Information
DRACP ID DRACP01304
Peptide Name Sequence 5 from Patent US 20070293424
Sequence VGGWGQPHGGG
Sequence Length 11
UniProt ID P40243
PubChem CID Not available
Origin Tragelaphus strepsiceros
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antimicrobial, Antitumor, Antiviral
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C44H61N15O13
Absent amino acids ACDEFIKLMNRSTY
Common amino acids G
Mass 118662
Pl 7.55
Basic residues 1
Acidic residues 0
Hydrophobic residues 2
Net charge 1
Boman Index 181
Hydrophobicity -67.27
Aliphatic Index 26.36
Half Life
Mammalian: 0.8 hour
Yeast: 10 min
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 550
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2007/0293424 A1
Patent Title Antitumoral and Antiviral Peptides.
Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: EP, RU, AU, ZA, US, WO; Legal Status: Active; Application No: 58571504 ; Filed:Dec 30, 2004; Published: Dec 20, 2007; Earliest Priority: Jan 15, 2004; Granted: Feb 12, 2013
Other Published ID EP1705182A1 EP1705182A4 EP1705182B1 US8372406 WO2005068491A1
This work is licensed under a Creative Commons Attribution 4.0 International License.